Important genetic abnormalities affecting the prognosis of glioma patients consist of IDH1/2 mutations, CDKN2A/B homozygous deletion, EGFR amplification, TP53 mutations, ATRX mutations, TERT promoter mutations, and 7 gain 10 loss chromosomal abnormalities [12]. This evidence concerns the gene TP53 and central nervous system cancer.